StonvexLoading…
StonvexStonvexStonvexCore line items from CNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | Not available | $374.00M | $1.58B | $1.19B | $795.00M |
Operating Income | Not available | $267.00M | $1.62B | $1.24B | $729.00M |
Net Income | Not available | $211.00M | $1.28B | $976.00M | $573.00M |
EPS (Diluted) | $1.02 | $0.78 | $4.69 | $3.58 | $2.10 |
Total Assets | Not available | $68.56B | $69.44B | $69.76B | $68.94B |
Total Liabilities | Not available | $57.70B | $57.82B | $58.43B | $58.27B |
Cash & Equivalents | Not available | $522.00M | $425.00M | $483.00M | $373.00M |
Free Cash Flow OCF − CapEx | Not available | $380.00M | $2.40B | $1.86B | $1.16B |
Shares Outstanding | Not available | 270.53M | 270.67M | 270.67M | 270.63M |